TWO · Healthcare

DIVA Laboratories Ltd (4153)

Diagnostics & Research

DIVA Laboratories Ltd (4153) is listed on TWO in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 4153

P/E ratio

18.00

DIVA Laboratories Ltd (4153) — FAQ

What is 4153's P/E ratio?

The price-to-earnings (P/E) ratio for DIVA Laboratories Ltd (4153) is 18.00 (data as of 2026-05-23).

Does DIVA Laboratories Ltd pay a dividend?

Dividend yield is not available in the current snapshot for DIVA Laboratories Ltd (4153). Check the MyAverix Finance app for the latest dividend data.

What sector is DIVA Laboratories Ltd in?

DIVA Laboratories Ltd (4153) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is 4153 listed on?

4153 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)